As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...
The Institute of Cancer Research, London, welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend the targeted drug talazoparib (trade name Talzenna), in ...
Work with the Institute of Cancer Research and help people with cancer. Enquire about trusts and foundations today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results